Saroja Pharma Industries India Beheer
Beheer criteriumcontroles 2/4
Saroja Pharma Industries India's CEO is Biju Nair, appointed in May 2023, has a tenure of 1.5 years. directly owns 72.05% of the company’s shares, worth ₹153.09M. The average tenure of the management team and the board of directors is 1.5 years and 1.5 years respectively.
Belangrijke informatie
Biju Nair
Algemeen directeur
₹3.8m
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | 1.5yrs |
| Eigendom CEO | 72.0% |
| Management gemiddelde ambtstermijn | 1.5yrs |
| Gemiddelde ambtstermijn bestuur | 1.5yrs |
Recente managementupdates
CEO
Biju Nair (54 yo)
1.5yrs
Tenure
₹3,840,000
Compensatie
Mr. Biju Gopinathan Nair has been Chairman and Managing Director of Saroja Pharma Industries India Limited since May 05, 2023 and an Executive Director since January 14, 2019. He highly motivated and enthu...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman & MD | 1.5yrs | ₹3.84m | 72.05% ₹ 153.1m | |
| Whole Time Director | no data | ₹1.56m | 0.97% ₹ 2.1m | |
| Chief Financial Officer | 1.5yrs | geen gegevens | geen gegevens | |
| Company Secretary & Compliance Officer | 1.7yrs | geen gegevens | geen gegevens |
1.5yrs
Gemiddelde duur
Ervaren management: SAROJA's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman & MD | 5.8yrs | ₹3.84m | 72.05% ₹ 153.1m | |
| Whole Time Director | 1.5yrs | ₹1.56m | 0.97% ₹ 2.1m | |
| Non-Executive & Independent Director | 1.5yrs | geen gegevens | geen gegevens | |
| Non-Independent & Non-Executive Director | 1.8yrs | geen gegevens | 0.000050% ₹ 106.2 | |
| Non-Executive & Independent Director | 1.5yrs | geen gegevens | geen gegevens | |
| Non-Executive & Independent Director | 1.5yrs | geen gegevens | geen gegevens |
1.5yrs
Gemiddelde duur
42.5yo
Gemiddelde leeftijd
Ervaren bestuur: SAROJA's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.